Indirubin是一具有抗炎症和抗癌活性的天然化合物。
Indirubin is a potent cyclin-dependent kinases and GSK-3β inhibitor with IC50 of about 5 μM and 0.6 μM.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Hoessel R, et al. Nat Cell Biol, 1999, 1(1), 60-67.
[2] Mei, Jianguo., et al., 2010. Synthesis of isoindigo-based oligothiophenes for molecular bulk heterojunction solar cells. Organic letters. 12(4): 660-3.
[3] Wee, Xi Kai., et al., 2009. Synthesis and evaluation of functionalized isoindigos as antiproliferative agents. Bioorganic & medicinal chemistry. 17(21): 7562-71.
[4] Adachi, J., et al., 2001. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. The Journal of biological chemistry. 276(34): 31475-8.
分子式 C16H10N2O2 |
分子量 262.26 |
CAS号 479-41-4 |
储存方式 ﹣20 ℃冷藏长期储存。冰袋运输 |
溶剂(常温) |
DMSO >50 mg/mL |
Water <1 mg/mL |
Ethanol <1 mg/mL |
体内溶解度
NCT Number | Conditions | Interventions | Sponsor/Collaborators | Phases | Start Date | Last Updated |
NCT02088281 | Psoriasis Vulgaris | Drug: Indigo naturalis extract in oil ointment | Chang Gung Memorial Hospital|National Science Council, Taiwan | Phase 2 | 2012-11-01 | 2014-03-12 |
NCT02200978 | Childhood Acute Promyelocytic Leukemia | Drug: ATO|Drug: RIF|Drug: ATRA|Drug: mitoxantrone|Drug: Ara-C|Drug: MTX|Drug: 6MP|Other: intrathecal injection | South China Children's Leukemia Group | Phase 4 | 2011-09-01 | 2016-04-28 |
NCT02669888 | Atopic Dermatitis | Drug: Indigo naturalis ointment|Drug: Placebo | Chang Gung Memorial Hospital|Ministry of Science and Technology, Taiwan | Phase 2 | 2015-10-01 | 2017-02-13 |
NCT01445886 | Nail Psoriasis | Drug: Indigo Naturalis Oil Extract|Drug: Calcipotriol Solution | Yin-ku Lin|Chang Gung University|Chang Gung Memorial Hospital | Phase 2|Phase 3 | 2011-01-01 | 2014-03-10 |
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们